Poliklinika pod Marjánkou

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• COPD2 trials

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Chiesi Farmaceutici S.p.A.2 trials

Closed trials

• Completed

  The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy

  NCT04636814· Phase 3· Chiesi Farmaceutici S.p.A.· Source

• Completed

  The efficacy and the safety of two doses of CHF6001 for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

  NCT04636801· Phase 3· Chiesi Farmaceutici S.p.A.· Source